Top Markets
Coin of the day
Allgens Medical Technology Co. Ltd. Allgens Medical Technology Co. Ltd.

Allgens Medical Technology Co. Ltd.

688613
Rang in Aktien #16116
Allgens Medical Technology Co. Ltd. operates as a medical device firm,... Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deployment in areas where both cancellous (spongy) and cortical (dense outer layer) bone tissues have been compromised. The company's diverse product portfolio includes key offerings such as BonGold, a mineralized collagen scaffold designed for bone grafting procedures; the high-performance Alligator bone marrow aspirator; and OssaNova, a mineralized collagen-based material utilized for bone filling and augmentation. These products are broadly applied across a spectrum of orthopedic and skeletal repair interventions throughout the human anatomy. Allgens Medical Technology Co. Ltd. was established in 2004 and is headquartered in Beijing, China.
Aktienkurs
$2.28
Marktkapitalisierung
$312.51M
Veränderung (1 Tag)
0.70%
Veränderung (1 Jahr)
-21.04%
Land
CN
Handel Allgens Medical Technology Co. Ltd. (688613)

Kategorie

Aktien-Split-Historie für Allgens Medical Technology Co. Ltd. (688613)
Die Aktie Allgens Medical Technology Co. Ltd. (Symbol: 688613) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Sep 01, 2026 statt.
Eine 688613-Aktie, die vor dem Sep 01, 2026 gekauft wurde, entspricht heute 0 688613-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
3 x12
US